Segregated Delivery of Rifampicin and Isoniazid from Fixed Dose Combination Bilayer Tablets for the Treatment of Tuberculosis

Journal Title: Journal of Pharmaceutical Research International - Year 2014, Vol 4, Issue 14

Abstract

Aims: Develop an anti-tuberculosis (TB) Fixed Dose Combination (FDC) tablet containing an immediate release layer (IRL) composed of both rifampicin (RIF) and pyrazinamide (PYR) and a retarded release layer (RRL) comprised of isoniazid (INH) which would allow segregated delivery of RIF and INH. Study Design: Trials were conducted on the pre-formulations and formulations to assess the compatibility of excipients and obtain a modified release profile, for an IRL consisting of both RIF and PYR and a RRL containing INH. Place and Duration of Study: This study was performed at the Laboratory of Pharmaceutical Industrial Technology, Drug and Pharmaceutical Department, Faculty of Pharmacy, between March 2008 and April 2010. Methodology: Preformulation studies were performed on RIF and PYR, alone and in combination with excipients. The pharmacopeic attributes of the distinct layers and the FDC tablets were evaluated for hardness, friability and disintegration time. The FDC bilayer tablets were analyzed for their drug content and cumulative dissolution of the drug. Results: Fourier transform infrared, x-ray diffraction and differential scanning calorimetry results revealed the presence of amorphous and crystalline RIF forms and no potentially relevant incompatibilities were identified in the kneaded system containing RIF, PYR and excipients. In vitro drug release from the FDC tablets revealed that the intragranular addition of croscarmellose sodium into the IRL rendered a cumulative dissolution of RIF and PYR within the limits of simulated gastric fluid. And, for RRL, the most effective retardant matrix excipient was found to be hydroxypropyl methylcellulose. Conclusion: Segregated delivery of RIF and INH from bilayer tablets is an option for the development of immediate release FDC tablets and the retarded release of INH, this strategy proved suitable for preventing contact of these two drugs under acidic conditions. This finding suggested that RIF had a high in vivo bioavailability which qualifies this FDC for future bioavailability studies.

Authors and Affiliations

A. M. Silva, B. Abrahim-Vieira, F. A. do Carmo, L. H. do Amaral, L. C. Silva, C. S. Escudini, M. A. Lopes, V. P. Sousa, H. C. Castro, F. Veiga, C. R. Rodrigues, A. J. Ribeiro, L. M. Cabral

Keywords

Related Articles

A Review on Tablet Scoring: Background, History and Current Regulatory Considerations

Tablet splitting or breaking of tablets into multiple strengths has been a common practice across the world. Splitting of tablet offers various advantages such as dose flexibility and ease of swallowing in different popu...

Incompatibility of Bisoprolol Fumarate with Some Super-disintegrating Agents

Aims: Bisoprolol fumarate, a selective β1adrenoreceptor blocker, is usually formulated as immediate release tablet dosage form. While developing the immediate release tablet formula in laboratory, the assay and dissoluti...

In vitro and in vivo Antitrypanosomal Effects of Methanol and Aqueous Extracts of Picralima nitida

The methanol and aqueous extracts of the leaves, fruits, seeds, stem bark and roots of Picralima nitida were studied in vitro and in vivo for activity against Trypanosoma brucei brucei in Swiss albino mice. Phytochemical...

Acute and Sub-acute Toxicity Studies of Ethanol Seed Extract of Raphia hookeri on Swiss Albino Rats

Aim: To evaluate the acute and sub-acute toxicities of Raphia hookeri (Rh) seed hydroethanolic extract on experimental animals. Materials and Methods: Acute toxicity study was evaluated on Swiss albino mice of both sexe...

Molecular Detection of Mycobacterium tuberculosis Complex by GenoType®MTBDRplus from Patients Attending Bingham University Teaching Hospital, Jos, Nigeria

Aims: The study was to investigate the presence of M. tuberculosis and the resistance to rifampicin and isoniazid in AFB-positive sputa of patients attending Bingham University Teaching Hospital, Jos, Nigeria. Study Desi...

Download PDF file
  • EP ID EP344716
  • DOI 10.9734/BJPR/2014/11525
  • Views 84
  • Downloads 0

How To Cite

A. M. Silva, B. Abrahim-Vieira, F. A. do Carmo, L. H. do Amaral, L. C. Silva, C. S. Escudini, M. A. Lopes, V. P. Sousa, H. C. Castro, F. Veiga, C. R. Rodrigues, A. J. Ribeiro, L. M. Cabral (2014). Segregated Delivery of Rifampicin and Isoniazid from Fixed Dose Combination Bilayer Tablets for the Treatment of Tuberculosis. Journal of Pharmaceutical Research International, 4(14), 1781-1801. https://europub.co.uk/articles/-A-344716